From: Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
Patient | Time-to-Treat [d] | Visual Gain | Follow-up [d] | Total Injections | Focal Laser [m] | Hemodilution | Intravitreal Triamcinolone [m] | Other |
---|---|---|---|---|---|---|---|---|
1 | 2232 | 0.0 | 119 | 1 | - | - | - | - |
2 | 59 | 0.8 | 57 | 1 | - | - | - | - |
3 | 19 | 0.2 | 341 | 4 | - | y | - | - |
4 | 77 | 0.2 | 172 | 2 | - | - | - | - |
5 | 6715 | 0.3 | 94 | 1 | -1 | - | - | - |
6 | 17 | 1.1 | 221 | 3 | +4,+13 | - | - | - |
7 | 37 | 0.7 | 250 | 3 | - | - | - | - |
8 | 211 | 0.2 | 109 | 1 | - | - | - | - |
9 | 6 | 0.0 | 91 | 1 | - | - | - | - |
10 | 1041 | 0.1 | 193 | 2 | - | - | - | - |
11 | 26 | -0.1 | 33 | 1 | - | - | - | - |
12 | 505 | 0.0 | 90 | 1 | -14,-12,-9,-8,-3,-2 | - | -14, +2 | - |
13 | 9 | 0.0 | 278 | 2 | +1,+2,+8,+12 | - | +9 | - |
14 | 456 | 0.6 | 236 | 2 | +1,+2,+3,+7 | - | -15 | - |
15 | 973 | 0.1 | 57 | 1 | -27,-24 | - | - | - |
16 | 598 | 0.2 | 27 | 1 | -8,-3 | - | -3 | - |
17 | 134 | 0.3 | 418 | 1 | -3,-2,+13 | - | - | - |
18 | 10 | 0.6 | 179 | 2 | - | - | - | - |
19 | 216 | 0.1 | 339 | 2 | +1 | - | - | - |
20 | 5 | -0.2 | 171 | 2 | +1,+4,+6 | - | - | - |
21 | 1794 | 0.3 | 284 | 4 | +1 | - | - | - |
22 | 5 | 0.3 | 38 | 1 | - | - | - | - |
23 | 64 | 0.2 | 48 | 1 | - | y | - | - |
24 | 254 | 0.1 | 234 | 4 | +2,+7 | - | - | - |
25 | 626 | 0.1 | 31 | 1 | - | - | - | - |
26 | 5 | -0.2 | 168 | 2 | - | - | - | - |
27 | 47 | 0.6 | 229 | 3 | +6,+7,+11 | - | - | - |
28 | 92 | -0.3 | 28 | 1 | -3 | - | - | - |
29 | 854 | 0.0 | 81 | 1 | - | - | - | vitrectomy at +2 m for tractive retinal detachment |
30 | 312 | 0.1 | 360 | 2 | -2,+7 | - | - | vitrectomy at +7 m for vitreous hemorrhage |
31 | 8 | 0.1 | 96 | 1 | - | - | - | - |
32 | 371 | 0.0 | 175 | 1 | - | - | - | - |